Drug Development, Packaging and Pharma Conference

Analysis Life Sciences Thank You What We Expect the FDA to do in May and June 2024

Agency IQ

MAY 3, 2024

Title Type Comments Close Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards Draft Guidance April 30 Early Alzheimer’s Disease: Developing Drugs for Treatment Draft Guidance May 13 Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the (..)

FDA

FDA Science Regulations Clinical Trials

Analysis Life Sciences Thank You What We Expect the FDA to do in August and September 2024

Agency IQ

AUGUST 2, 2024

Start Date End Date Event Event Type Center 07/30/2024 07/30/2024 Environmental Monitoring in Compounding Virtual CDER 08/02/2024 08/02/2024 UPDATED PUBLIC PARTICIPATION INFORMATION: August 2, 2024: Meeting of the Genetic Metabolic Diseases Advisory Committee Meeting Announcement Advisory Committee Meeting CDER 08/07/2024 08/07/2024 Medical Device (..)

FDA

FDA Science Regulations Biosimilars

Drug Discovery Digest

Analysis Life Sciences Thank You What We Expect the FDA to do in May and June 2024

Analysis Life Sciences Thank You What We Expect the FDA to do in August and September 2024

Webinars

Stay Connected